WEE1 INHIBITOR FOR CANCER

Disclosed herein is a WEE1 compound, or a pharmaceutically acceptable salt thereof, alone or in combination with a KRAS inhibitor, or a pharmaceutically acceptable salt thereof, for treating a disease or condition, such as a colorectal, pancreatic and/or non-small cell lung cancer. En la presente de...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SAMATAR Ahmed Abdi, BUNKER Kevin Duane, DONATE Fernando, DE JONG Petrus Rudolf, HUANG Peter Qinhua, IZADI Hooman
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed herein is a WEE1 compound, or a pharmaceutically acceptable salt thereof, alone or in combination with a KRAS inhibitor, or a pharmaceutically acceptable salt thereof, for treating a disease or condition, such as a colorectal, pancreatic and/or non-small cell lung cancer. En la presente descripción se describe un compuesto de WEE1, o una sal farmacéuticamente aceptable de este, solo o en combinación con un inhibidor de KRAS, o una sal farmacéuticamente aceptable de este, para tratar una enfermedad o afección, tal como un cáncer colorrectal, de páncreas y/o de pulmón de células no pequeñas.